Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
Standard
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. / Kirchhof, Paulus; Lip, Gregory Y H; Gelder, Van; Isabelle, C; Bax, Jeroen; Hylek, Elaine; Kääb, Stefan; Wegscheider, Karl; Wegscheider, Karl; Boriani, Giuseppe; Ezekowitz, Michael; Diener, Hans; Heidbuchel, Hein; Lane, Deirdre; Willems, Stephan; Willems, Stephan; Dorian, Paul; Vardas, Panos; Breithardt, Günter; Camm, A John.
in: THROMB HAEMOSTASIS, Jahrgang 106, Nr. 6, 6, 2011, S. 1012-1019.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
AU - Kirchhof, Paulus
AU - Lip, Gregory Y H
AU - Gelder, Van
AU - Isabelle, C
AU - Bax, Jeroen
AU - Hylek, Elaine
AU - Kääb, Stefan
AU - Wegscheider, Karl
AU - Wegscheider, Karl
AU - Boriani, Giuseppe
AU - Ezekowitz, Michael
AU - Diener, Hans
AU - Heidbuchel, Hein
AU - Lane, Deirdre
AU - Willems, Stephan
AU - Willems, Stephan
AU - Dorian, Paul
AU - Vardas, Panos
AU - Breithardt, Günter
AU - Camm, A John
PY - 2011
Y1 - 2011
N2 - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.
AB - There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.
KW - Humans
KW - Practice Guidelines as Topic
KW - Risk Factors
KW - Europe
KW - Biological Markers/metabolism
KW - Fibrinolytic Agents/therapeutic use
KW - Atrial Fibrillation/classification/diagnosis/drug therapy/physiopathology
KW - Risk Reduction Behavior
KW - Humans
KW - Practice Guidelines as Topic
KW - Risk Factors
KW - Europe
KW - Biological Markers/metabolism
KW - Fibrinolytic Agents/therapeutic use
KW - Atrial Fibrillation/classification/diagnosis/drug therapy/physiopathology
KW - Risk Reduction Behavior
M3 - SCORING: Journal article
VL - 106
SP - 1012
EP - 1019
JO - THROMB HAEMOSTASIS
JF - THROMB HAEMOSTASIS
SN - 0340-6245
IS - 6
M1 - 6
ER -
